Under a technology transfer arrangement with Hyderabad-based company Covaxin producer Bharat Biotech, Haffkine Biopharma will produce 22.8 crore doses of Covaxin. These companies are Haffkine Biopharmaceutical Corporation Limited, Mumbai, Indian Immunological Limited, Hyderabad and Bharat Immunological & Biological Limited, Bulandshahr, UP. Dr Sandeep Rathod, Managing Director, Haffkine Biopharma said that the company proposes to produce 2.28 crore doses of Covaxin in a year. He added that "Haffkine Biopharma has received a grant of Rs 65 crore by the Center and Rs 94 crore by the Maharashtra government for the production of Covaxin." Rathod, a doctor-turned-IAS, said that the vaccine production process involves two phases - the drug formulation and the final drug production.

Source: dna June 02, 2021 10:52 UTC